DEFA14A: Replimune Group Announces 2025 Annual Stockholders Meeting Details and Proxy Proposals
Annual Meeting Proxy Notice
Replimune Group, Inc. has issued a definitive additional materials filing providing notice and details for its 2025 Annual Meeting of Stockholders, including proposals for director elections, auditor ratification, executive compensation, and an incentive plan amendment.
Summary
- The 2025 Annual Meeting of Stockholders for Replimune Group, Inc. will be held virtually on Wednesday, September 3, 2025, at 11:30 A.M. Eastern time.
- Stockholders can access the virtual meeting via meetnow.global/MF6VJVT.
- Proxy materials, including the 2025 Proxy Statement and Annual Report on Form 10-K for the fiscal year ended March 31, 2025, are available online at www.envisionreports.com/REPL.
- The Board of Directors recommends a vote FOR all five director nominees: Kapil Dhingra, Christy Oliger, Joseph Slattery, Michael Goller, and Philip Astley-Sparke.
- The Board recommends a vote FOR the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026.
- A non-binding advisory vote on the compensation of named executive officers for the fiscal year ended March 31, 2025, is proposed, with a Board recommendation of FOR.
- An amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan is proposed for approval, with a Board recommendation of FOR.
- Requests for paper copies of proxy materials must be received by August 22, 2025, to facilitate timely delivery.
Sentiment
Score: 5
Explanation: The filing is a routine procedural notice for an annual meeting, containing no positive or negative financial or operational news, thus indicating a neutral sentiment.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding future financial performance or strategic outlook, focusing instead on procedural matters for the upcoming annual meeting.
Industry Context
This filing is a standard procedural notice for an annual stockholders' meeting, common across publicly traded companies, and does not provide specific insights into broader industry trends or competitive positioning beyond routine corporate governance matters.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Proposed Plan Amendment | Approval of an amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan. | NA | If approved, this amendment could impact future equity compensation for employees and executives, potentially affecting dilution and long-term incentive structures. |
Stakeholder Impact
- Shareholders are directly impacted as they are required to vote on key corporate governance matters, including the election of directors, ratification of auditors, executive compensation, and an incentive plan amendment.
- Employees may be indirectly impacted by the proposed amendment to the 2018 Omnibus Incentive Compensation Plan, which could affect their equity-based compensation.
Next Steps
- Stockholders are encouraged to view proxy materials and vote online at www.envisionreports.com/REPL.
- Stockholders can request a paper copy of proxy materials via internet, phone, or email by August 22, 2025.
- Stockholders can attend and vote at the virtual annual meeting on September 3, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-08-22 | Deadline to request a paper copy of proxy materials for timely delivery. |
| 2025-09-03 | Date of the 2025 Annual Meeting of Stockholders, held virtually at 11:30 A.M. Eastern time. |
| 2026-03-31 | End of the fiscal year for which PricewaterhouseCoopers LLP is proposed as the independent registered public accounting firm. |
Keywords
Replimune Group, Annual Meeting, Proxy Statement, Stockholders Meeting, Corporate Governance, Director Election, Auditor Ratification, Executive Compensation, Incentive Plan, SEC Filing, DEFA14A
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.